15-hydroxyeicosatrienoic acid has been researched along with Asthma, Bronchial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fadok, VA; Huynh, ML; Kotaru, C; Malcolm, KC; Tilstra, JA; Wenzel, SE; Westcott, JY | 1 |
Bienkiewicz, B; Jedrzejczak-Czechowicz, M; Kowalski, ML; Lewandowska-Polak, A | 1 |
2 other study(ies) available for 15-hydroxyeicosatrienoic acid and Asthma, Bronchial
Article | Year |
---|---|
Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Apoptosis; Asthma; Bronchoalveolar Lavage Fluid; Case-Control Studies; Cell Survival; Chronic Disease; Dexamethasone; Dinoprostone; Female; Forced Expiratory Volume; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Jurkat Cells; Macrophages, Alveolar; Male; Phagocytosis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vital Capacity | 2005 |
Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics.
Topics: Adolescent; Adult; Aged; Arachidonate 15-Lipoxygenase; Aspirin; Asthma; Caffeic Acids; Dinoprostone; Drug Hypersensitivity; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes; Lipoxygenase Inhibitors; Male; Middle Aged; Misoprostol; Receptors, Prostaglandin E | 2008 |